[HTML][HTML] The key role of mitochondrial function in health and disease

I San-Millán - Antioxidants, 2023 - mdpi.com
The role of mitochondrial function in health and disease has become increasingly
recognized, particularly in the last two decades. Mitochondrial dysfunction as well as …

Ceramides in metabolism: key lipotoxic players

B Chaurasia, SA Summers - Annual review of physiology, 2021 - annualreviews.org
The global prevalence of metabolic diseases such as type 2 diabetes mellitus,
steatohepatitis, myocardial infarction, and stroke has increased dramatically over the past …

Ceramides–lipotoxic inducers of metabolic disorders

B Chaurasia, SA Summers - Trends in Endocrinology & Metabolism, 2015 - cell.com
In obesity and dyslipidemia, the oversupply of fat to tissues not suited for lipid storage
induces cellular dysfunction that underlies diabetes and cardiovascular disease (ie …

Plasma ceramides: a novel predictor of major adverse cardiovascular events after coronary angiography

JW Meeusen, LJ Donato, SC Bryant… - … , and vascular biology, 2018 - Am Heart Assoc
Objective—Ceramides are sphingolipids involved with cellular signaling. Synthesis of
ceramides occurs in all tissues. Ceramides accumulate within tissues and the blood plasma …

[HTML][HTML] The role of smoking in the mechanisms of development of chronic obstructive pulmonary disease and atherosclerosis

S Kotlyarov - International Journal of Molecular Sciences, 2023 - mdpi.com
Tobacco smoking is a major cause of chronic obstructive pulmonary disease (COPD) and
atherosclerotic cardiovascular disease (ASCVD). These diseases share common …

[HTML][HTML] Emerging roles of ceramide in cardiovascular diseases

H Shu, Y Peng, W Hang, N Li, N Zhou… - Aging and …, 2022 - ncbi.nlm.nih.gov
Ceramide is a core molecule of sphingolipid metabolism that causes selective insulin
resistance and dyslipidemia. Research on its involvement in cardiovascular diseases has …

[HTML][HTML] The dark side of sphingolipids: searching for potential cardiovascular biomarkers

P Di Pietro, C Izzo, AC Abate, P Iesu, MR Rusciano… - Biomolecules, 2023 - mdpi.com
Cardiovascular diseases (CVDs) are the leading cause of death and illness in Europe and
worldwide, responsible for a staggering 47% of deaths in Europe. Over the past few years …

[HTML][HTML] Circulating ceramides as biomarkers of cardiovascular disease: Evidence from phenotypic and genomic studies

KA McGurk, BD Keavney, A Nicolaou - Atherosclerosis, 2021 - Elsevier
There is a need for new biomarkers of atherosclerotic cardiovascular disease (ACVD), the
main cause of death globally. Ceramides, a class of potent bioactive lipid mediators, have …

[HTML][HTML] Sphingolipids and atherosclerosis: the dual role of ceramide and sphingosine-1-phosphate

M Piccoli, F Cirillo, A Ghiroldi, P Rota, S Coviello… - Antioxidants, 2023 - mdpi.com
Sphingolipids are bioactive molecules that play either pro-and anti-atherogenic roles in the
formation and maturation of atherosclerotic plaques. Among SLs, ceramide and sphingosine …

[HTML][HTML] Advances in the pharmacological study of Chinese herbal medicine to alleviate diabetic nephropathy by improving mitochondrial oxidative stress

M Chen, Y Chen, W Zhu, X Yan, J Xiao, P Zhang… - Biomedicine & …, 2023 - Elsevier
Diabetic nephropathy (DN) is one of the serious complications of diabetes mellitus, primarily
arising from type 2 diabetes (T2DM), and can progress to chronic kidney disease (CKD) and …